MINNEAPOLIS, Aug. 19 /PRNewswire-FirstCall/ -- Protectus Medical Devices, Inc. ("Protectus Medical Devices") (OTCQB: PTMD), a developer and marketer of innovative medical devices, today named physician/surgeon Dr. Dan Hartley as Medical Director.
Dr. Hartley has vast experience in research and development in pharmaceutical and medical device industries, including quality control, medical writing and regulatory compliance. He has served as a clinical data auditor and has held senior level clinical research associate positions at several major pharmaceutical companies.
Dr. Hartley will establish the Protectus Medical Advisory Board, oversee quality control, compliance and assurance, and serve as a medical spokesperson helping to establish Protectus as the world leader in medical safety devices, such as its patented Safety Syringe.
The Protectus Safety Syringe is the only fully automatic, self-sheathing safety hypodermic syringe that currently meets all U.S. Federal Government and OSHA mandates designed to protect both healthcare workers and patients alike. It is designed to significantly reduce or eliminate accidental needlestick injuries that have plagued the healthcare workplace for decades. More information about Protectus Medical Devices may be found at the Company's corporate website at www.protectusmedical.com.
According to Protectus CEO and President Dr. John Salstroms, "Dr. Hartley will bring unmatched experience, passion, and commitment toward achieving our goal of developing the safest needle devices in the healthcare workplace to protect the health and well-being of workers and patients worldwide."
Dr. Hartley will be involved with a broad range of Protectus Safety Syringes, including: the Safety IV Catheter (patent-pending); Safety Dental Syringe (patent pending), both using the same patented safety designed engineering as the Safety Syringe, and soon to be announced Phlebotomy device.
About Protectus Medical Devices, Inc. (formerly, E-18 Corp.)Protectus Medical Devices, Inc. (PTMD, formerly, E-18 Corp.), through its wholly owned subsidiary, SquareOne Medical, Inc., develops and markets innovative safety medical percutaneous devices that, collectively, have the potential to dramatically reduce needlestick injuries for medical professionals worldwide. In the nearly $5 billion global hypodermic syringe market, the Protectus Safety Syringe, the Company's lead product, is the only fully automatic, self-sheathing hypodermic safety syringe that currently meets the functional definition of "Self-Sheathing" mandated by the U.S. Federal Government. None of the manufacturers of other devices on the market can make this claim. Protectus Medical Devices has successfully patented its automatic, self-sheathing hypodermic safety syringe product, and, based on the results of full comparison clinical trials, the Protectus Safety Syringe (formerly the SquareOne Safety Syringe) has received the required 510(k) permission from the U.S. FDA to manufacture and market the device in the U.S. More information about the Company may be found at www.protectusmedical.com.
Forward-Looking StatementsThis release contains "forward-looking statements" for purposes of the Securities and Exchange Commission's "safe harbor" provisions under the Private Securities Litigation Reform Act of 1995 and Rule 3b-6 under the Securities Exchange Act of 1934. These forward-looking statements are subject to various risks and uncertainties that could cause the business and financial results of Protectus Medical Devices, Inc. to differ materially from those currently anticipated, including the risk factors identified in Protectus Medical Devices, Inc.'s filings with the Securities and Exchange Commission.Company Contact:Protectus Medical Devices, Inc. John Salstrom, President and CEOPh: email@example.com
|SOURCE Protectus Medical Devices, Inc.|
Copyright©2010 PR Newswire.
All rights reserved